Decoding innovation: 3 key lessons on the testing frontier

Room 4 | 9:00 am - 9:30 am | Tuesday, March 26, 2024

Set out on a thought-provoking journey into innovation, where the stakes are high – only 1 in 20 ventures succeeds and consumers often resist change. Yet, the risk of not innovating is even greater, as evidenced by industry examples. Delve into three crucial lessons to mitigate early-stage risks: navigate the strategic dance between quantitative and qualitative insights; embrace the benefits of early packaging tests over delayed evaluations; recognize the vital importance of testing within context vs. standalone.

Featured speakers include Shilpa Khanna, associate director of transformational growth insights at Clorox Company, and Cliff Kane, new business development director at EyeSee, each bringing over 18 years of expertise in insights and innovation strategy.

Key Takeaways:

1. The strategic relationship between quantitative and qualitative insights.
2. The advantages of early packaging tests versus delayed evaluations.
3. The essential importance of testing in-context rather than standalone.